Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
Monoisotopic mass
309.194008357
InChI
InChI=1S/C17H27NO4/c1-17(2,3)18-9-12(19)10-22-16-6-4-5-11-7-14(20)15(21)8-13(11)16/h4-6,12,14-15,18-21H,7-10H2,1-3H3/t12?,14-,15+/m1/s1
InChI Key
InChIKey=VWPOSFSPZNDTMJ-UCWKZMIHSA-N
IUPAC Name
(2R,3S)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol
Traditional IUPAC Name
nadolol
SMILES
CC(C)(C)NCC(O)COC1=CC=CC2=C1C[C@H](O)[C@H](O)C2
Độ hòa tan
8330 mg/L (at 25 °C)
pKa (strongest acidic)
13.59
pKa (Strongest Basic)
9.76
Refractivity
85.53 m3·mol-1
Dược Lực Học :
Nadolol is a nonselective beta-adrenergic receptor antagonist with a long half-life, and is structurally similar to propranolol. Clinical pharmacology studies have demonstrated beta-blocking activity by showing (1) reduction in heart rate and cardiac output at rest and on exercise, (2) reduction of systolic and diastolic blood pressure at rest and on exercise, (3) inhibition of isoproterenol-induced tachycardia, and (4) reduction of reflex orthostatic tachycardia. Nadolol has no intrinsic sympathomimetic activity and, unlike some other beta-adrenergic blocking agents, nadolol has little direct myocardial depressant activity and does not have an anesthetic-like membrane-stabilizing action.
Cơ Chế Tác Dụng :
A non-selective beta-adrenergic antagonist with a long half-life, used in cardiovascular disease to treat arrhythmias, angina pectoris, and hypertension. Nadolol is also used for migraine disorders and for tremor. [PubChem]
Like other beta-adrenergic antagonists, nadolol competes with adrenergic neurotransmitters such as catecholamines for binding at sympathetic receptor sites. Like propranolol and timolol, nadolol binds at beta(1)-adrenergic receptors in the heart and vascular smooth muscle, inhibiting the effects of the catecholamines epinephrine and norepinephrine and decreasing heart rate, cardiac output, and systolic and diastolic blood pressure. It also blocks beta-2 adrenergic receptors located in bronchiole smooth muscle, causing vasoconstriction. By binding beta-2 receptors in the juxtaglomerular apparatus, nadolol inhibits the production of renin, thereby inhibiting angiotensin II and aldosterone production. Nadolol therefore inhibits the vasoconstriction and water retention due to angiotensin II and aldosterone, respectively.
Dược Động Học :
▧ Absorption :
Absorption of nadolol after oral dosing is variable, averaging about 30 percent.
▧ Protein binding :
30%
▧ Metabolism :
Not metabolized by the liver and excreted unchanged primarily by the kidneys.
▧ Route of Elimination :
Unlike many other beta-adrenergic blocking agents, nadolol is not metabolized by the liver and is excreted unchanged, principally by the kidneys. Nadolol is excreted predominantly in the urine.
▧ Half Life :
14-24 hours
Độc Tính :
Oral, mouse: LD50 = 4500mg/kg. Symptoms of overdose include abdominal irritation, central nervous system depression, coma, extremely slow heartbeat, heart failure, lethargy, low blood pressure, and wheezing.
Chỉ Định :
Used in cardiovascular disease to treat arrhythmias, angina pectoris, and hypertension.
Tương Tác Thuốc :
-
Acetohexamide
The beta-blocker, nadolol, may decrease symptoms of hypoglycemia.
-
Aminophylline
Antagonism of action and increased effect of theophylline
-
Chlorpropamide
The beta-blocker, nadolol, may decrease symptoms of hypoglycemia.
-
Clonidine
Increased hypertension when clonidine stopped
-
Dihydroergotamine
Ischemia with risk of gangrene.
-
Disopyramide
The beta-blocker, nadolol, may increase the toxicity of disopyramide.
-
Dyphylline
Antagonism of action and increased effect of theophylline
-
Epinephrine
Hypertension, then bradycardia
-
Ergonovine
Ischemia with risk of gangrene
-
Ergotamine
Ischemia with risk of gangrene
-
Fenoterol
Antagonism
-
Formoterol
Antagonism
-
Gliclazide
The beta-blocker, nadolol, may decrease symptoms of hypoglycemia.
-
Glipizide
The beta-blocker, nadolol, may decrease symptoms of hypoglycemia.
-
Glisoxepide
The beta-blocker, nadolol, may decrease symptoms of hypoglycemia.
-
Glyburide
The beta-blocker, nadolol, may decrease symptoms of hypoglycemia.
-
Glycodiazine
The beta-blocker, nadolol, may decrease symptoms of hypoglycemia.
-
Ibuprofen
Risk of inhibition of renal prostaglandins
-
Indomethacin
Risk of inhibition of renal prostaglandins
-
Insulin Glargine
The beta-blocker, nadolol, may decrease symptoms of hypoglycemia.
-
Isoprenaline
Antagonism
-
Lidocaine
The beta-blocker, nadolol, may decrease symptoms of hypoglycemia.
-
Methyldopa
Possible hypertensive crisis
-
Methysergide
Ischemia with risk of gangrene
-
Orciprenaline
Antagonism
-
Oxtriphylline
Antagonism of action and increased effect of theophylline
-
Pipobroman
Antagonism
-
Pirbuterol
Antagonism
-
Piroxicam
Risk of inhibition of renal prostaglandins
-
Prazosin
Risk of hypotension at the beginning of therapy
-
Procaterol
Antagonism
-
Repaglinide
The beta-blocker, nadolol, may decrease symptoms of hypoglycemia.
-
Salbutamol
Antagonism
-
Salmeterol
Antagonism
-
Terazosin
Increased risk of hypotension. Initiate concomitant therapy cautiously.
-
Terbutaline
Antagonism
-
Theophylline
Antagonism of action and increased effect of theophylline
-
Tolazamide
The beta-blocker, nadolol, may decrease symptoms of hypoglycemia.
-
Tolbutamide
The beta-blocker, nadolol, may decrease symptoms of hypoglycemia.
-
Treprostinil
Additive hypotensive effect. Monitor antihypertensive therapy during concomitant use.
-
Verapamil
Increased effect of both drugs
Liều Lượng & Cách Dùng :
Tablet - Oral
Dữ Kiện Thương Mại
Giá thị trường
-
Giá bán buôn : USD >1.03
Đơn vị tính : tablet
-
Giá bán buôn : USD >1.07
Đơn vị tính : tablet
-
Giá bán buôn : USD >1.26
Đơn vị tính : tablet
-
Giá bán buôn : USD >1.45
Đơn vị tính : tablet
-
Giá bán buôn : USD >2.25
Đơn vị tính : tablet
-
Giá bán buôn : USD >3.04
Đơn vị tính : tablet
-
Giá bán buôn : USD >3.11
Đơn vị tính : tablet
-
Giá bán buôn : USD >3.96
Đơn vị tính : tablet
-
Giá bán buôn : USD >4.33
Đơn vị tính : tablet
-
Giá bán buôn : USD >4.4
Đơn vị tính : tablet
-
Giá bán buôn : USD >94.8
Đơn vị tính : g
-
Giá bán buôn : USD >0.26
Đơn vị tính : tablet
-
Giá bán buôn : USD >0.26
Đơn vị tính : tablet
-
Giá bán buôn : USD >0.37
Đơn vị tính : tablet
-
Giá bán buôn : USD >0.37
Đơn vị tính : tablet
-
Giá bán buôn : USD >0.92
Đơn vị tính : tablet
Nhà Sản Xuất
-
Sản phẩm biệt dược : Anabet
-
Sản phẩm biệt dược : Corgard
-
Sản phẩm biệt dược : Solgol
Tài Liệu Tham Khảo Thêm
National Drug Code Directory